Timely access to new drugs in a single-payer system: policy analysis from South Korea's reimbursement framework
{{output}}
Background: Timely access to innovative medicines remains a policy challenge in single-payer systems. South Korea has introduced mechanisms such as economic evaluation exemptions and risk-sharing agreements (RSAs) to improve acce... ...
